Updating results

251 results

Sort: Relevance | Date

Cladribine tablets for treating relapsing–remitting multiple sclerosis (TA493)

This guidance has been updated and replaced by NICE technology appraisal guidance 616.

Technology appraisal guidance Published December 2017